{"id":"W2619722962","doi":"10.17925/ohr.2017.13.01.19","title":"Raising the Bar in Advanced Pancreatic Cancer","year":2017,"lang":"en","type":"article","venue":"touchREVIEWS in Oncology & Haematology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"FOLFIRINOX; Gemcitabine; Medicine; Oxaliplatin; Irinotecan; Pancreatic cancer; Oncology; Internal medicine; Randomized controlled trial; Clinical trial; First line; Cancer; Colorectal cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005795728,0.0004385812,0.00126409,0.001039264,0.001304655,0.004000841,0.001182845,0.005232876,0.007421138],"category_scores_gemma":[0.01534345,0.0002861374,0.0007254657,0.001062352,0.003983893,0.006475102,0.003637459,0.01255743,0.003280456],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001818048,"about_ca_system_score_gemma":0.002247787,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001243883,"about_ca_topic_score_gemma":0.002486448,"domain_scores_codex":[0.9980597,0.0008377928,0.0001729389,0.0002356146,0.0004731685,0.000220676],"domain_scores_gemma":[0.9905246,0.005298458,0.000564066,0.0004606516,0.001728411,0.001423829],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003064086,0.00006699996,0.001362205,0.003378859,0.0000933097,0.0007084672,0.0004635581,0.0003212186,0.0008315349,0.02565674,0.4078799,0.5589308],"study_design_scores_gemma":[0.0000528385,0.0001398399,0.001228824,0.002830691,0.00005143382,0.001156799,0.0006536296,0.0001054727,0.0002839781,0.02717395,0.9662882,0.0000343003],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001171602,0.7520903,0.0007040887,0.2234677,0.01727761,0.000009065171,0.00005331378,0.00007311969,0.005153196],"genre_scores_gemma":[0.02420126,0.787612,0.001299523,0.1121247,0.06933386,0.00002907102,0.0001186617,0.00008119014,0.005199666],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.007421138,"threshold_uncertainty_score":0.03065115,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1171455752535715,"score_gpt":0.475567786133746,"score_spread":0.3584222108801745,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}